top of page

Andrew Evens, DO MSc

Director, Lymphoma Program

Rutgers Cancer Institute of New Jersey

Dr. Evens is Associate Director for Clinical Services and Director, Lymphoma Program, Rutgers Cancer Institute; Medical Director, Oncology Service Line, RWJBarnabas Health; Associate Director for Clinical Services; Medical Director of the Oncology Service Line for RWJ Barnabas Health; and Director of the Lymphoma Program. He served as the director of the Cancer Center at Tufts Medical Center in Boston, chief of their division of hematology/oncology, and Professor of Medicine at Tufts University School of Medicine

Dr Evens is an expert in Hodgkin lymphoma, non-Hodgkin lymphoma (all types), chronic lymphocytic leukemia, and autologous hematopoietic stem cell (or bone marrow) transplantation. He manages a translational laboratory studying the biology of lymphoma and to discover new and novel treatments for patients.

Dr. Evens a core member of the Hodgkin Lymphoma Working Group for the NIH/NCI Steering Committee and a member of several additional clinical and scientific committees for the NIH, NCI, Cancer Therapy Evaluation Program (CTEP), Food and Drug Administration (FDA) and the ECOG/ACRIN group. He is also Vice-Chair of the Lymphoma Committee for the ECOG-ACRIN cancer research group and an elected member of the North American Scientific Advisory Board for the Lymphoma Research Foundation (LRF) and a member of the Board of Trustees for the Leukemia & Lymphoma Society (LLS) New Jersey Chapter.

Dr. Evens completed a prior fellowship in hematology/oncology at Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center in Chicago, Illinois, where he remained as a faculty member altogether for 10 years.

bottom of page